Literature DB >> 17991806

On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis.

Vey Hadinoto1, Michael Shapiro, Thomas C Greenough, John L Sullivan, Katherine Luzuriaga, David A Thorley-Lawson.   

Abstract

Memory B cells latently infected with Epstein-Barr virus (mB(Lats)) in the blood disappear rapidly on presentation with acute symptomatic primary infection (acute infectious mononucleosis [AIM]). They undergo a simple exponential decay (average half-life: 7.5 +/- 3.7 days) similar to that of normal memory B cells. The cytotoxic T lymphocyte (CTL) response to immediate early (IE) lytic antigens (CTL(IEs)) also decays over this time period, but no such correlation was observed for the CTL response to lytic or latent antigens or to the levels of virions shed into saliva. We have estimated the average half-life of CTL(IEs) to be 73 (+/- 23) days. We propose that cycles of infection and reactivation occur in the initial stages of infection that produce high levels of mB(Lats) in the circulation. Eventually the immune response arises and minimizes these cycles leaving the high levels of mB(Lats) in the blood to decay through simple memory B-cell homeostasis mechanisms. This triggers the cells to reactivate the virus whereupon most are killed by CTL(IEs) before they can release virus and infect new cells. The release of antigens caused by this large-scale destruction of infected cells may trigger the symptoms of AIM and be a cofactor in other AIM-associated diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17991806      PMCID: PMC2214734          DOI: 10.1182/blood-2007-06-093278

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

Review 1.  Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.

Authors:  T Pierson; J McArthur; R F Siliciano
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells.

Authors:  Michelle D Catalina; John L Sullivan; Robin M Brody; Katherine Luzuriaga
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

Review 3.  Epstein-Barr virus: exploiting the immune system.

Authors:  D A Thorley-Lawson
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

4.  The dispersal of mucosal memory B cells: evidence from persistent EBV infection.

Authors:  Lauri L Laichalk; Donna Hochberg; Gregory J Babcock; Richard B Freeman; David A Thorley-Lawson
Journal:  Immunity       Date:  2002-05       Impact factor: 31.745

5.  Influence of EBV on the peripheral blood memory B cell compartment.

Authors:  Tatyana A Souza; B David Stollar; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

6.  Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.

Authors:  G J Inman; U K Binné; G A Parker; P J Farrell; M J Allday
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.

Authors:  M D Catalina; J L Sullivan; K R Bak; K Luzuriaga
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

8.  Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load.

Authors:  S L Silins; M A Sherritt; J M Silleri; S M Cross; S L Elliott; M Bharadwaj; T T Le; L E Morrison; R Khanna; D J Moss; A Suhrbier; I S Misko
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

9.  Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.

Authors:  Julia Kurth; Martin-Leo Hansmann; Klaus Rajewsky; Ralf Küppers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-28       Impact factor: 11.205

10.  Characteristics of Hodgkin's lymphoma after infectious mononucleosis.

Authors:  Henrik Hjalgrim; Johan Askling; Klaus Rostgaard; Stephen Hamilton-Dutoit; Morten Frisch; Jin-Song Zhang; Mette Madsen; Nils Rosdahl; Helle Bossen Konradsen; Hans H Storm; Mads Melbye
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

View more
  46 in total

1.  Modeling the dynamics of virus shedding into the saliva of Epstein-Barr virus positive individuals.

Authors:  Giao T Huynh; Libin Rong
Journal:  J Theor Biol       Date:  2012-06-07       Impact factor: 2.691

Review 2.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 3.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

4.  Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number.

Authors:  Jill E Roughan; Charles Torgbor; David A Thorley-Lawson
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

5.  Investigation on the association between thyroid tumorigeneses and herpesviruses.

Authors:  J F M Almeida; A H Campos; M A Marcello; N E Bufalo; C L Rossi; L H P Amaral; A B Marques; L L Cunha; C A Alvarenga; P C Tincani; A J Tincani; L S Ward
Journal:  J Endocrinol Invest       Date:  2017-03-08       Impact factor: 4.256

Review 6.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

7.  EBV promotes human CD8 NKT cell development.

Authors:  Yuling He; Ruijing Xiao; Xiang Ji; Li Li; Lang Chen; Jie Xiong; Wei Xiao; Yujuan Wang; Lijun Zhang; Rui Zhou; Xinti Tan; Yongyi Bi; Yan-Ping Jiang; Youxin Jin; Jinquan Tan
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

8.  Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage.

Authors:  Thomas C Greenough; Shalyn C Campellone; Robin Brody; Surbhi Jain; Victor Sanchez-Merino; Mohan Somasundaran; Katherine Luzuriaga
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

9.  Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.

Authors:  Nicholas Renzette; Mohan Somasundaran; Frank Brewster; James Coderre; Eric R Weiss; Margaret McManus; Thomas Greenough; Barbara Tabak; Manuel Garber; Timothy F Kowalik; Katherine Luzuriaga
Journal:  J Virol       Date:  2014-01-15       Impact factor: 5.103

10.  The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output.

Authors:  Vey Hadinoto; Michael Shapiro; Chia Chi Sun; David A Thorley-Lawson
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.